Clinical Trial Update: Phase III Presbyopia Correction Using the VIS Opti-K™ System [Phase 3]

View source ↗

Summary

Phase III clinical trial update for presbyopia correction using the VIS Opti-K system; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Presbyopia

Drugs mentioned

• VIS Opti-K System

Snippet

Sponsor: VIS, Inc. | Conditions: Presbyopia | Phase 3 | Status: RECRUITING